Form 4: Elanco Director John P. Bilbrey Receives Stock Grant and Disposes of Shares

Elanco Animal Health director John P. Bilbrey received a grant of 18,169 deferred stock units and disposed of 78,400 common shares held in a revocable trust.

Summary

• John P. Bilbrey, a director at Elanco Animal Health, received 18,169 deferred stock units as part of an annual equity award for non-employee board members.
• Bilbrey also disposed of 78,400 common shares held indirectly through a revocable trust.
• Following these transactions, Bilbrey directly owns 78,400 common shares and indirectly owns 41,722 common shares through the revocable trust.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock grant and share disposal by a director. It doesn't indicate any significant positive or negative sentiment, but the share disposal could be viewed with slight caution.

Positives

• The grant of deferred stock units aligns the director's interests with the company's long-term performance.
• The equity award is a standard practice for non-employee board members.

Negatives

• The disposal of 78,400 shares by the director could be interpreted negatively by the market, although it is not clear why the shares were disposed of.

Risks

• The disposal of a significant number of shares by a director could potentially signal a lack of confidence in the company's future performance, although this is not necessarily the case.
• Market sentiment could be negatively impacted by the share disposal.

Industry Context

This type of transaction is common for directors of publicly traded companies, as they often receive equity-based compensation as part of their overall package. The filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Equity grants to non-employee directors are a standard practice across publicly traded companies, including those in the animal health sector.
• Companies like Zoetis and IDEXX Laboratories also provide similar equity-based compensation to their board members.
• The size of the grant and the number of shares disposed of are specific to Elanco and Bilbrey's situation, but the overall practice is consistent with industry norms.

Stakeholder Impact

• Shareholders may be interested in the director's transactions as they can provide insights into management's view of the company's prospects.
• The disposal of shares could potentially cause a slight negative reaction in the market.

Key Dates

Keywords

Elanco Animal Health, John P. Bilbrey, stock grant, deferred stock units, share disposal, director, equity award, insider trading, beneficial ownership